Get started
PACIRA BIOSCIENCES INCPACIRA BIOSCIENCES INCPACIRA BIOSCIENCES INC

PACIRA BIOSCIENCES INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

82P chart


Full chart

82P upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪734.47 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.77 EUR
Net income (FY)
‪38.01 M‬ EUR
Revenue (FY)
‪611.54 M‬ EUR
Shares float
‪44.56 M‬
Beta (1Y)
0.93

Employees


Employees (FY)
712
Change (1Y)
−3 −0.42%
Revenue / Employee (1Y)
‪948.00 K‬ EUR
Net income / Employee (1Y)
‪58.93 K‬ EUR

About Pacira BioSciences, Inc.


Sector
Health Technology
CEO
Frank D. Lee
Headquarters
Tampa
Website
pacira.com
Founded
2006
FIGI
BBG001HTR121
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

82P news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

82P highest yielding bonds


PCRX5221546
Pacira Biosciences, Inc. 0.75% 01-AUG-2025
Yield to maturity
5.06%
Maturity date
Aug 1, 2025

Explore more bonds 

Frequently Asked Questions


The current price of 82P is 15.60 EUR — it has increased by 0.64% in the past 24 hours. Watch PACIRA BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PACIRA BIOSCIENCES INC stocks are traded under the ticker 82P.
82P stock has fallen by −2.47% compared to the previous week, the month change is a 6.76% rise, over the last year PACIRA BIOSCIENCES INC has showed a −40.91% decrease.
We've gathered analysts' opinions on PACIRA BIOSCIENCES INC future price: according to them, 82P price has a max estimate of 36.39 EUR and a min estimate of 7.46 EUR. Watch 82P chart and read a more detailed PACIRA BIOSCIENCES INC stock forecast: see what analysts think of PACIRA BIOSCIENCES INC and suggest that you do with its stocks.
82P reached its all-time high on Apr 11, 2022 with the price of 75.00 EUR, and its all-time low was 10.30 EUR and was reached on Aug 12, 2024. View more price dynamics on 82P chart.
See other stocks reaching their highest and lowest prices.
82P stock is 3.27% volatile and has beta coefficient of 0.93. Track PACIRA BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is PACIRA BIOSCIENCES INC there?
Today PACIRA BIOSCIENCES INC has the market capitalization of ‪734.47 M‬, it has increased by 6.34% over the last week.
Yes, you can track PACIRA BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
PACIRA BIOSCIENCES INC is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
82P earnings for the last quarter are 0.71 EUR per share, whereas the estimation was 0.63 EUR resulting in a 12.14% surprise. The estimated earnings for the next quarter are 0.74 EUR per share. See more details about PACIRA BIOSCIENCES INC earnings.
PACIRA BIOSCIENCES INC revenue for the last quarter amounts to ‪151.40 M‬ EUR, despite the estimated figure of ‪152.28 M‬ EUR. In the next quarter, revenue is expected to reach ‪169.33 M‬ EUR.
82P net income for the last quarter is ‪−128.85 M‬ EUR, while the quarter before that showed ‪17.63 M‬ EUR of net income which accounts for −830.79% change. Track more PACIRA BIOSCIENCES INC financial stats to get the full picture.
No, 82P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 712.00 employees. See our rating of the largest employees — is PACIRA BIOSCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PACIRA BIOSCIENCES INC EBITDA is ‪159.90 M‬ EUR, and current EBITDA margin is 24.13%. See more stats in PACIRA BIOSCIENCES INC financial statements.
Like other stocks, 82P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PACIRA BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PACIRA BIOSCIENCES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PACIRA BIOSCIENCES INC stock shows the sell signal. See more of PACIRA BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.